Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025
Outset Medical (Nasdaq: OM), a medical technology company focused on revolutionizing dialysis technology, has scheduled its first quarter 2025 financial results announcement for Wednesday, May 7, 2025, after market close.
The company will host a conference call at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on the same day, featuring Chair and CEO Leslie Trigg and CFO Nabeel Ahmed to discuss the financial and operating results. Interested participants can register online to receive dial-in details and a unique pin for the call.
A live and archived webcast will be available on the company's investor relations website.
Outset Medical (Nasdaq: OM), un'azienda di tecnologia medica dedicata a rivoluzionare la tecnologia per la dialisi, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per mercoledì 7 maggio 2025, dopo la chiusura del mercato.
La società terrà una conference call alle 14:00 ora del Pacifico (17:00 ora dell'Est) dello stesso giorno, con la partecipazione della Presidente e CEO Leslie Trigg e del CFO Nabeel Ahmed, per discutere i risultati finanziari e operativi. Gli interessati possono registrarsi online per ricevere i dettagli per la chiamata e un codice PIN univoco.
Una webcast in diretta e archiviata sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda.
Outset Medical (Nasdaq: OM), una empresa de tecnología médica enfocada en revolucionar la tecnología de diálisis, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el miércoles 7 de mayo de 2025, después del cierre del mercado.
La compañía realizará una llamada en conferencia a las 2:00 p.m. hora del Pacífico (5:00 p.m. hora del Este) ese mismo día, con la participación de la Presidenta y CEO Leslie Trigg y el CFO Nabeel Ahmed para discutir los resultados financieros y operativos. Los interesados pueden registrarse en línea para recibir los detalles de acceso y un código PIN único para la llamada.
Habrá una transmisión en vivo y archivada disponible en el sitio web de relaciones con inversionistas de la compañía.
Outset Medical (나스닥: OM)는 투석 기술 혁신에 주력하는 의료 기술 회사로, 2025년 1분기 재무 실적 발표를 2025년 5월 7일 수요일 시장 마감 후에 예정했습니다.
회사는 같은 날 태평양 시간 오후 2시(동부 시간 오후 5시)에 회장 겸 CEO 레슬리 트리그(Leslie Trigg)와 CFO 나빌 아메드(Nabeel Ahmed)가 참석하는 컨퍼런스 콜을 개최하여 재무 및 운영 실적에 대해 논의할 예정입니다. 관심 있는 참가자는 온라인으로 등록하여 전화 접속 정보와 고유 PIN을 받을 수 있습니다.
라이브 및 아카이브 웹캐스트는 회사의 투자자 관계 웹사이트에서 제공됩니다.
Outset Medical (Nasdaq : OM), une entreprise de technologie médicale spécialisée dans la révolution de la technologie de dialyse, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le mercredi 7 mai 2025, après la clôture du marché.
La société organisera une conférence téléphonique à 14h00 heure du Pacifique (17h00 heure de l'Est) le même jour, avec la présidente et CEO Leslie Trigg ainsi que le CFO Nabeel Ahmed pour discuter des résultats financiers et opérationnels. Les participants intéressés peuvent s'inscrire en ligne pour recevoir les informations d'accès et un code PIN unique pour l'appel.
Un webcast en direct et en différé sera disponible sur le site web des relations investisseurs de la société.
Outset Medical (Nasdaq: OM), ein Medizintechnikunternehmen, das sich auf die Revolutionierung der Dialysetechnologie spezialisiert hat, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Mittwoch, den 7. Mai 2025, nach Börsenschluss geplant.
Das Unternehmen wird am selben Tag um 14:00 Uhr Pazifikzeit (17:00 Uhr Ostküstenzeit) eine Telefonkonferenz abhalten, bei der Vorsitzende und CEO Leslie Trigg sowie CFO Nabeel Ahmed die finanziellen und operativen Ergebnisse besprechen. Interessierte Teilnehmer können sich online registrieren, um Einwahldaten und eine individuelle PIN für das Gespräch zu erhalten.
Ein Live- und ein archivierter Webcast werden auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
SAN JOSE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter 2025 after the close of trading on Wednesday, May 7, 2025.
On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.
Conference Call Details
The conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, May 7, 2025. Those interested in joining the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
Contact
Jim Mazzola
Investor Relations
jmazzola@outsetmedical.com
